+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Chitosan-based Hemostatic Gauze Market - Global Forecast 2026-2032- Product Image
Chitosan-based Hemostatic Gauze Market - Global Forecast 2026-2032- Product Image
Sale

Chitosan-based Hemostatic Gauze Market - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6118550
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Chitosan-based Hemostatic Gauze Market is projected to reach USD 168.38 Million in 2026. It is expected to continue growing at a CAGR of 16.48%, reaching USD 431.24 Million by 2032.

Chitosan-Based Hemostatic Gauze: Executive Overview

Chitosan-based hemostatic gauze is an emergency and surgical bleeding-control material that uses chitosan’s bioadhesive and positively charged polymer structure to support clot formation when applied to a wound. Its relevance is strongest where rapid hemorrhage control, compact medical kits, and use in austere or resource-constrained settings are priorities. Product evaluation typically considers bleeding-control performance, handling, shelf stability, biocompatibility, sterilization, packaging, and regulatory status.

Clinical and Operational Shifts Reshaping Hemostatic Gauze

The landscape is being shaped by demand for faster prehospital intervention, increasingly standardized trauma protocols, and wider preparedness for mass-casualty, military, disaster-response, and remote-care scenarios. Buyers are also placing greater emphasis on ease of application, limited training requirements, radiopacity or wound visibility where relevant, compatibility with established first-aid systems, and clear instructions for removal and follow-up care. Regulatory scrutiny is encouraging stronger evidence on safety, performance, shelf life, and consistency across production batches.

How Artificial Intelligence Is Influencing the Value Chain

Artificial intelligence is contributing indirectly but increasingly across product development, quality assurance, logistics, and clinical workflow design. Machine-learning tools can help analyze bleeding-control evidence, identify formulation or packaging variables for further testing, detect manufacturing anomalies, and improve inventory positioning for emergency supplies. In clinical environments, decision-support systems may assist triage and protocol adherence, although AI does not replace trained assessment, immediate wound management, or validated medical guidance. Data governance, explainability, cybersecurity, and prospective validation remain necessary before AI-supported processes are used in high-risk care.

Regional Insights Across Six Healthcare Environments

North America is characterized by established trauma systems, prehospital procurement, military applications, and relatively mature regulatory and evidence requirements. Europe combines coordinated medical-device regulation with diverse national procurement practices and strong interest in clinical utility and sustainability. Asia-Pacific presents varied healthcare infrastructure, expanding emergency-care capacity, domestic manufacturing capabilities, and significant differences in regulatory pathways across markets. Latin America’s adoption context is influenced by uneven access, public-sector purchasing, trauma burdens, and the need for dependable products suited to decentralized care. The Middle East is supported by investment in advanced hospitals, emergency preparedness, and defense-related medical capabilities, while procurement can vary substantially by country. Africa’s opportunities are closely linked to humanitarian response, rural and mobile care, supply reliability, affordability, and training for first responders.

Group Insights: ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN markets require approaches that accommodate diverse regulatory systems, island and rural logistics, and differing levels of emergency-care maturity. BRICS members span large and highly varied healthcare systems, making local evidence, resilient distribution, and public procurement engagement important. The European Union emphasizes harmonized compliance alongside national purchasing and hospital-level evaluation. G7 settings generally place strong weight on clinical evidence, quality systems, traceability, and integration with advanced trauma networks. GCC countries often combine centralized purchasing, sophisticated hospital infrastructure, and emergency-preparedness priorities. NATO-related demand is associated with military medicine, interoperability, field deployability, and standardized trauma training, while civilian applications remain subject to each member’s healthcare and regulatory framework.

Country Perspectives: Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Russia, South Korea, Spain, the UK, and the US

Australia’s dispersed population and remote-care requirements favor portable, shelf-stable bleeding-control products supported by structured trauma services. Brazil and Mexico must balance major urban trauma capacity with uneven access across regions, making distribution and practical training important. Canada’s geography reinforces the value of prehospital and remote-use applications. China and India combine large healthcare systems with domestic manufacturing potential, varied hospital capabilities, and evolving procurement requirements. Japan and South Korea emphasize quality, reliability, and integration with advanced clinical systems. France, Germany, Italy, Spain, and the United Kingdom operate within sophisticated European healthcare and regulatory environments, with national and institutional differences in purchasing and evidence review. The United States has broad use cases across civilian trauma, emergency medical services, defense, and preparedness, accompanied by demanding regulatory and procurement expectations. Russia’s operating environment is shaped by domestic supply considerations, emergency medicine needs, and applicable national regulatory requirements.

Actions for Leaders: Prove Performance, Simplify Use, and Strengthen Resilience

Industry leaders should prioritize well-designed evidence that clearly defines the bleeding scenarios, comparators, application techniques, and user populations relevant to each intended claim. Product development should focus on intuitive handling, secure packaging, low training burden, and dependable performance under transport and storage conditions. Regulatory and procurement strategies should be tailored by jurisdiction rather than treated as universally transferable. Leaders should also build resilient supply chains for medical-grade raw materials, qualify alternate suppliers, maintain rigorous batch testing, and document post-market performance. Partnerships with trauma networks, first-responder organizations, humanitarian groups, and military medical educators can improve training quality and generate practical feedback without overstating clinical benefits.

Research Methodology for a Evidence-Based Market Assessment

This executive summary uses a structured secondary-research framework centered on the product category and its application context. The assessment should triangulate peer-reviewed clinical and materials-science literature, regulatory records, public procurement documents, trauma and emergency-care guidelines, standards, hospital protocols, and information from credible public-health and humanitarian institutions. Findings should be compared across geographies and user groups while distinguishing demonstrated product performance from broader category-level assumptions. Because the available reference identifies the category but provides no quantitative evidence, this summary intentionally excludes market estimates, shares, sizing, and forecasts.

Conclusion: Reliable Hemorrhage Control Depends on Evidence and Execution

Chitosan-based hemostatic gauze occupies an important role in rapid bleeding control, particularly where portability, speed, and use outside fully equipped operating environments matter. Its long-term relevance will depend on credible clinical evidence, consistent manufacturing, clear regulatory positioning, practical training, and supply-chain resilience. Regional and group-level differences mean that successful adoption requires localized procurement, education, and implementation strategies. Artificial intelligence can strengthen development and operations, but validated clinical judgment and disciplined quality systems remain central to safe use.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Chitosan-based Hemostatic Gauze Market, by Product Type
7.1. Introduction
7.2. Gauze Pad
7.3. Impregnated Gauze
7.4. Non-Woven Gauze
8. Chitosan-based Hemostatic Gauze Market, by Application
8.1. Introduction
8.2. Emergency Care
8.3. First Aid
8.4. Military Use
8.5. Surgical Procedures
8.5.1. Cardiovascular
8.5.2. General Surgery
8.5.3. Orthopedic
9. Chitosan-based Hemostatic Gauze Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Clinics
9.4. Emergency Medical Services
9.5. Hospitals
9.5.1. Private Hospitals
9.5.2. Public Hospitals
9.6. Trauma Centers
10. Chitosan-based Hemostatic Gauze Market, by Sales Channel
10.1. Introduction
10.2. Offline
10.3. Online
11. Chitosan-based Hemostatic Gauze Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Chitosan-based Hemostatic Gauze Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Chitosan-based Hemostatic Gauze Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Aegis Lifesciences Pvt. Ltd.
15.2. Anping Guardian Medical Equipment Co., Ltd.
15.3. Axio Biosolutions Pvt. Ltd.
15.4. Biophrame Technologies, SAS
15.5. ChitoTech Co.
15.6. Guangzhou Rainhome Pharm & Tech Co., Ltd.
15.7. Hangzhou Singclean Medical Products Co., Ltd.
15.8. HemCon Medical Technologies, Inc.
15.9. Marine Polymer Technologies, Inc.
15.10. MedTrade Products Ltd.
15.11. Ningbo Risenmed Technology Co., Ltd.
15.12. North American Rescue, LLC
15.13. Ore-Medix, LLC
15.14. PerSys Medical, LLC
15.15. Qingdao DMD Medical Technology Co., Ltd.
15.16. Smith & Nephew plc
15.17. Teleflex Incorporated
15.18. Tricol Biomedical, Inc.
15.19. Yangzhou Super Union Medical Material Co., Ltd.
15.20. Zhejiang Perfectseal Medical Co., Ltd.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Chitosan-based Hemostatic Gauze Market, Years Considered for the Study
FIGURE 2. Global Chitosan-based Hemostatic Gauze Market, Research Design
FIGURE 3. Global Chitosan-based Hemostatic Gauze Market, Research Framework
FIGURE 4. Global Chitosan-based Hemostatic Gauze Market, Data Triangulation
FIGURE 5. Global Chitosan-based Hemostatic Gauze Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Chitosan-based Hemostatic Gauze Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global Chitosan-based Hemostatic Gauze Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Chitosan-based Hemostatic Gauze Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Chitosan-based Hemostatic Gauze Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2025 vs 2032 (%)
FIGURE 13. Global Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Chitosan-based Hemostatic Gauze Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Chitosan-based Hemostatic Gauze Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Chitosan-based Hemostatic Gauze Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Chitosan-based Hemostatic Gauze Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Chitosan-based Hemostatic Gauze Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Chitosan-based Hemostatic Gauze Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Chitosan-based Hemostatic Gauze Market Segmentation & Coverage
TABLE 2. Global Chitosan-based Hemostatic Gauze Market Size, 2017-2032 (USD Million)
TABLE 3. Global Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Gauze Pad Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Gauze Pad Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Gauze Pad Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Impregnated Gauze Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Impregnated Gauze Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Impregnated Gauze Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Non-Woven Gauze Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Non-Woven Gauze Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Non-Woven Gauze Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 14. Global Emergency Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Emergency Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Emergency Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global First Aid Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global First Aid Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global First Aid Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Military Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Military Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Military Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Surgical Procedures Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Surgical Procedures Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Surgical Procedures Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Cardiovascular Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Cardiovascular Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Cardiovascular Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global General Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global General Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global General Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Orthopedic Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Orthopedic Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Orthopedic Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 36. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Emergency Medical Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Emergency Medical Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Emergency Medical Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Trauma Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Trauma Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Trauma Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 58. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Chitosan-based Hemostatic Gauze Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Chitosan-based Hemostatic Gauze Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 72. North America Chitosan-based Hemostatic Gauze Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. North America Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 74. North America Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 75. North America Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 76. North America Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 77. North America Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 78. North America Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 79. Latin America Chitosan-based Hemostatic Gauze Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Latin America Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 81. Latin America Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 82. Latin America Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 83. Latin America Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 84. Latin America Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 85. Latin America Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 86. Europe Chitosan-based Hemostatic Gauze Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Europe Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 88. Europe Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 89. Europe Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 90. Europe Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 91. Europe Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 92. Europe Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 93. Middle East Chitosan-based Hemostatic Gauze Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Middle East Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 95. Middle East Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 96. Middle East Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 97. Middle East Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 98. Middle East Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 99. Middle East Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 100. Africa Chitosan-based Hemostatic Gauze Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Africa Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 102. Africa Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 103. Africa Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 104. Africa Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 105. Africa Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 106. Africa Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 107. Global Chitosan-based Hemostatic Gauze Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. ASEAN Chitosan-based Hemostatic Gauze Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. ASEAN Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 110. ASEAN Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 111. ASEAN Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 112. ASEAN Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 113. ASEAN Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 114. ASEAN Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 115. GCC Chitosan-based Hemostatic Gauze Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. GCC Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 117. GCC Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 118. GCC Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 119. GCC Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. GCC Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 121. GCC Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 122. European Union Chitosan-based Hemostatic Gauze Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. European Union Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 124. European Union Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. European Union Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 126. European Union Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 127. European Union Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 128. European Union Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 129. BRICS Chitosan-based Hemostatic Gauze Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. BRICS Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 131. BRICS Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. BRICS Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 133. BRICS Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 134. BRICS Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 135. BRICS Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 136. G7 Chitosan-based Hemostatic Gauze Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. G7 Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 138. G7 Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 139. G7 Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 140. G7 Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. G7 Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 142. G7 Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 143. NATO Chitosan-based Hemostatic Gauze Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. NATO Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 145. NATO Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. NATO Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 147. NATO Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 148. NATO Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 149. NATO Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 150. Global Chitosan-based Hemostatic Gauze Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. United States Chitosan-based Hemostatic Gauze Market Size, 2017-2032 (USD Million)
TABLE 152. United States Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 153. United States Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 154. United States Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 155. United States Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 156. United States Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 157. United States Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 158. Canada Chitosan-based Hemostatic Gauze Market Size, 2017-2032 (USD Million)
TABLE 159. Canada Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 160. Canada Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. Canada Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 162. Canada Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. Canada Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 164. Canada Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 165. Mexico Chitosan-based Hemostatic Gauze Market Size, 2017-2032 (USD Million)
TABLE 166. Mexico Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 167. Mexico Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 168. Mexico Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 169. Mexico Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. Mexico Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 171. Mexico Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 172. Brazil Chitosan-based Hemostatic Gauze Market Size, 2017-2032 (USD Million)
TABLE 173. Brazil Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 174. Brazil Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. Brazil Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 176. Brazil Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. Brazil Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 178. Brazil Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 179. United Kingdom Chitosan-based Hemostatic Gauze Market Size, 2017-2032 (USD Million)
TABLE 180. United Kingdom Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 181. United Kingdom Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 182. United Kingdom Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 183. United Kingdom Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 184. United Kingdom Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 185. United Kingdom Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 186. Germany Chitosan-based Hemostatic Gauze Market Size, 2017-2032 (USD Million)
TABLE 187. Germany Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 188. Germany Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. Germany Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 190. Germany Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 191. Germany Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 192. Germany Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 193. France Chitosan-based Hemostatic Gauze Market Size, 2017-2032 (USD Million)
TABLE 194. France Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 195. France Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 196. France Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 197. France Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 198. France Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 199. France Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 200. Russia Chitosan-based Hemostatic Gauze Market Size, 2017-2032 (USD Million)
TABLE 201. Russia Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 202. Russia Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 203. Russia Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 204. Russia Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. Russia Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 206. Russia Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 207. Italy Chitosan-based Hemostatic Gauze Market Size, 2017-2032 (USD Million)
TABLE 208. Italy Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 209. Italy Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. Italy Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 211. Italy Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 212. Italy Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 213. Italy Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 214. Spain Chitosan-based Hemostatic Gauze Market Size, 2017-2032 (USD Million)
TABLE 215. Spain Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 216. Spain Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 217. Spain Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 218. Spain Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 219. Spain Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 220. Spain Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 221. China Chitosan-based Hemostatic Gauze Market Size, 2017-2032 (USD Million)
TABLE 222. China Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 223. China Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 224. China Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 225. China Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. China Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 227. China Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 228. India Chitosan-based Hemostatic Gauze Market Size, 2017-2032 (USD Million)
TABLE 229. India Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 230. India Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 231. India Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 232. India Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 233. India Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 234. India Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 235. Japan Chitosan-based Hemostatic Gauze Market Size, 2017-2032 (USD Million)
TABLE 236. Japan Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 237. Japan Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 238. Japan Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 239. Japan Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 240. Japan Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 241. Japan Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 242. Australia Chitosan-based Hemostatic Gauze Market Size, 2017-2032 (USD Million)
TABLE 243. Australia Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 244. Australia Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 245. Australia Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 246. Australia Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 247. Australia Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 248. Australia Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 249. South Korea Chitosan-based Hemostatic Gauze Market Size, 2017-2032 (USD Million)
TABLE 250. South Korea Chitosan-based Hemostatic Gauze Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 251. South Korea Chitosan-based Hemostatic Gauze Market Size, by Application, 2017-2032 (USD Million)
TABLE 252. South Korea Chitosan-based Hemostatic Gauze Market Size, by Surgical Procedures, 2017-2032 (USD Million)
TABLE 253. South Korea Chitosan-based Hemostatic Gauze Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. South Korea Chitosan-based Hemostatic Gauze Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 255. South Korea Chitosan-based Hemostatic Gauze Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 256. Global Chitosan-based Hemostatic Gauze Market Share, by Key Player, 2025
TABLE 257. Global Chitosan-based Hemostatic Gauze Market, Key Experts

Companies Mentioned

  • Aegis Lifesciences Pvt. Ltd.
  • Anping Guardian Medical Equipment Co., Ltd.
  • Axio Biosolutions Pvt. Ltd.
  • Biophrame Technologies, SAS
  • ChitoTech Co.
  • Guangzhou Rainhome Pharm & Tech Co., Ltd.
  • Hangzhou Singclean Medical Products Co., Ltd.
  • HemCon Medical Technologies, Inc.
  • Marine Polymer Technologies, Inc.
  • MedTrade Products Ltd.
  • Ningbo Risenmed Technology Co., Ltd.
  • North American Rescue, LLC
  • Ore-Medix, LLC
  • PerSys Medical, LLC
  • Qingdao DMD Medical Technology Co., Ltd.
  • Smith & Nephew plc
  • Teleflex Incorporated
  • Tricol Biomedical, Inc.
  • Yangzhou Super Union Medical Material Co., Ltd.
  • Zhejiang Perfectseal Medical Co., Ltd.

Related Topics

Related Reports

Bio-based Hemostatic Powder Market - Global Forecast 2026-2032 - Product Image

Bio-based Hemostatic Powder Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Chitosan Hemostatic Material Market - Global Forecast 2026-2032 - Product Image

Chitosan Hemostatic Material Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Chitosan-Based Hemostasis Management Products Global Market Report 2026 - Product Image

Chitosan-Based Hemostasis Management Products Global Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Biomaterial Wound Dressing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Biomaterial Wound Dressing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
Topical Absorbable Hemostats Market Report 2026 - Product Image

Topical Absorbable Hemostats Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.